World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
25565
World Ranking
11898
National Ranking
6102

Garrett L. Walsh publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Garrett L. Walsh sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 348 publications — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Garrett L. Walsh D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Garrett L. Walsh sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 91 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Garrett L. Walsh is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on the field of Medicine, with a significant emphasis on Pulmonary and Respiratory Medicine, Surgery, and Oncology. Additional areas of study include Radiology, Nuclear Medicine and Imaging, as well as Economics and Econometrics.

The main topics covered in Garrett L. Walsh's work encompass Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Esophageal Cancer Research and Treatment, Cancer Immunotherapy and Biomarkers, Gastric Cancer Management and Outcomes, Radiomics and Machine Learning in Medical Imaging, and Esophageal and GI Pathology.

Frequent co-authors collaborating with Garrett L. Walsh include:

  • Reza J. Mehran
  • Stephen G. Swisher
  • Ara A. Vaporciyan
  • David C. Rice
  • Mara B. Antonoff

Garrett L. Walsh has published multiple papers in notable journals. Some recent publications include:

  • "Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial," 2021, Nature Medicine
  • "Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery," 2021, The Lancet Oncology
  • "Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial," 2023, Nature Medicine
  • "Neoadjuvant Chemotherapy Increases Cytotoxic T Cell, Tissue Resident Memory T Cell, and B Cell Infiltration in Resectable NSCLC," 2020, Journal of Thoracic Oncology
  • "Definition and assessment of high risk in patients considered for lobectomy for stage I non-small cell lung cancer: The American Association for Thoracic Surgery expert panel consensus document," 2021, Journal of Thoracic and Cardiovascular Surgery

The most frequent publication venues for Garrett L. Walsh's work include:

  • Journal of Thoracic and Cardiovascular Surgery
  • The Annals of Thoracic Surgery
  • Journal of Surgical Oncology
  • Seminars in Thoracic and Cardiovascular Surgery
  • Annals of Surgery

Best Publications

  • Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer.

    J. A. Roth;D. Nguyen;D. D. Lawrence;B. L. Kemp

  • Adenovirus-Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung Cancer

    Stephen G. Swisher;Jack A. Roth;John Nemunaitis;David D. Lawrence

  • Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial.

    Tina Cascone;William N. William;Annikka Weissferdt;Cheuk H. Leung

  • Clonal Genetic Alterations in the Lungs of Current and Former Smokers

    Li Mao;Jin Soo Lee;Jonathan M Kurie;You Hong Fan

  • Survival in early-stage non-small cell lung cancer

    Jonathan C. Nesbitt;Joe B. Putnam;Garrett L. Walsh;Jack A. Roth

  • Transthoracic vertebrectomy for metastatic spinal tumors

    Ziya L. Gokaslan;Julie E. York;Garrett L. Walsh;Ian E. McCutcheon

  • Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer.

    Stephen G. Swisher;Linda DeFord;Kelly Willis Merriman;Garrett L. Walsh

  • Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients

    Ara A Vaporciyan;Arlene M Correa;David C Rice;Jack A Roth

  • Adenovirus-Mediated p53 Gene Transfer in Sequence With Cisplatin to Tumors of Patients With Non–Small-Cell Lung Cancer

    J. Nemunaitis;S.G. Swisher;T. Timmons;D. Connors

  • Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: Final report

    Edward S Kim;Joe B Putnam;Ritsuko Komaki;Garrett L Walsh

  • Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer

    Stephen G. Swisher;Mary Maish;Jeremy J. Erasmus;Arlene M. Correa

  • Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus

    Jonathan C Nesbitt;Ernesto R Soltero;Colin P.N Dinney;Garrett L Walsh

  • 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma.

    Stephen G. Swisher;Jeremy Erasmus;Mary Maish;Arlene M. Correa

  • Treatment Outcomes of Resected Esophageal Cancer

    Wayne Hofstetter;Stephen G. Swisher;Arlene M. Correa;Kenneth Hess

  • Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy

    Stephen G. Swisher;Paula Wynn;Joe B. Putnam;Melinda B. Mosheim

  • Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy.

    Stephen G Swisher;Jack A Roth;Ritsuko Komaki;Jian Gu

  • Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter

    Joe B. Putnam;Garrett L. Walsh;Stephen G. Swisher;Jack A. Roth

  • Management of primary pulmonary artery sarcomas.

    Shanda H. Blackmon;David C Rice;Arlene M Correa;Reza John Mehran

  • Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma.

    David C. Rice;Craig W. Stevens;Arlene M. Correa;Ara A. Vaporciyan

  • Is follow-up of lung cancer patients after resection medically indicated and cost-effective?

    Garrett L Walsh;Maeve O'Connor;Kelly M. Willis;Mira Milas

Frequent Co-Authors

Jack A. Roth
Jack A. Roth The University of Texas MD Anderson Cancer Center
Ara A. Vaporciyan
Ara A. Vaporciyan The University of Texas MD Anderson Cancer Center
David C. Rice
David C. Rice The University of Texas MD Anderson Cancer Center
Stephen G. Swisher
Stephen G. Swisher The University of Texas MD Anderson Cancer Center
Wayne L. Hofstetter
Wayne L. Hofstetter The University of Texas MD Anderson Cancer Center
Joe B. Putnam
Joe B. Putnam The University of Texas MD Anderson Cancer Center
Jaffer A. Ajani
Jaffer A. Ajani The University of Texas MD Anderson Cancer Center
Ritsuko Komaki
Ritsuko Komaki The University of Texas MD Anderson Cancer Center
Waun Ki Hong
Waun Ki Hong The University of Texas MD Anderson Cancer Center
Jonathan M. Kurie
Jonathan M. Kurie The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring related online degrees can open new doors for those interested in healthcare fields beyond traditional medical school. One increasingly popular route is pursuing a cheapest dnp programs, which allows registered nurses to reach the highest clinical level while minimizing costs.

For aspiring nurses, online lpn programs offer a fast-track entry into the nursing profession. These courses are flexible and ideal for those seeking a quicker start to a healthcare career.

Specialization is another path to consider. Those interested in mental health can earn an advanced degree through online psych np programs, giving them skills to address growing needs in psychiatric and mental health services.

Administration roles are also critical in healthcare. Completing a bachelors in health administration prepares professionals to manage hospitals, clinics, or care facilities and drive system-wide improvements.

Ultimately, online degrees offer affordable, flexible pathways into diverse healthcare careers—each with unique rewards and challenges.

Best Scientists Citing Garrett L. Walsh

Trending Scientists

Recently Published Articles